Ignite Creation Date:
2025-12-25 @ 2:51 AM
Ignite Modification Date:
2026-02-27 @ 5:09 PM
Study NCT ID:
NCT04247633
Status:
UNKNOWN
Last Update Posted:
2020-04-20
First Post:
2020-01-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
High Risk ER+HER2- T1-2N0-1 Early Breast Cancer With Palbociclib Plus Endocrine Therapy(HIPEx)
Sponsor:
Samsung Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-02-11
Start Date Type:
ACTUAL
Primary Completion Date:
2023-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-02
Completion Date Type:
ESTIMATED
First Submit Date:
2020-01-27
First Submit QC Date:
None
Study First Post Date:
2020-01-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-04-17
Last Update Post Date:
2020-04-20
Last Update Post Date Type:
ACTUAL